Bajaj Healthcare Promoter Group Member Acquires 7,095 Equity Shares in Open Market

Bajaj Healthcare Limited has received a disclosure from promoter group member Anil Champalal Jain regarding the acquisition of 7,095 equity shares through open market purchase. The transaction, completed on March 17, 2026, was formally disclosed on March 18, 2026, in compliance with SEBI regulations.

Transaction Details

Anil Champalal Jain, who serves as Managing Director and is a member of the promoter group, acquired the shares through open market purchase. The acquisition represents a marginal increase in his shareholding in the pharmaceutical company.

Parameter:	Details
Shares Acquired:	7,095 equity shares
Acquisition Date:	March 17, 2026
Acquisition Mode:	Open Market Purchase
Disclosure Date:	March 18, 2026
Acquirer Status:	Promoter Group Member

Shareholding Pattern Changes

The acquisition resulted in a slight increase in Jain's overall shareholding in Bajaj Healthcare Limited. His total holding now includes both equity shares and warrants/convertible securities.

Holding Category:	Before Acquisition	After Acquisition	Change
Equity Shares:	14,74,375	14,81,470	+7,095
Warrants/Convertible Securities:	4,55,074	4,55,074	No change
Total Holdings:	19,29,449	19,36,544	+7,095
Percentage of Share Capital:	6.11%	6.13%	+0.02%
Percentage of Diluted Capital:	5.73%	5.75%	+0.02%

Company Capital Structure

Bajaj Healthcare Limited's equity share capital remains unchanged following this transaction. The company maintains its existing capital structure with no impact from this promoter group acquisition.

Capital Details:	Amount
Total Equity Shares:	3,15,83,252 shares
Face Value per Share:	₹5
Total Share Capital:	₹15,79,16,260
Diluted Share Capital:	₹16,83,13,305
Total Diluted Shares:	3,36,62,661 shares

Regulatory Compliance

The disclosure was made under Regulation 29(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The company's shares are listed on both BSE Limited and National Stock Exchange of India Limited. The formal disclosure document was digitally signed and submitted to comply with regulatory filing requirements.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-0.53%	-1.23%	-5.95%	-35.43%	-53.92%	-14.58%

Bajaj Healthcare Limited has successfully completed the allotment of 20,79,409 equity shares following the conversion of convertible warrants by 8 investors. The board meeting held on March 18, 2026, approved the allotment at an issue price of ₹338 per share, including a premium of ₹333 per share.

Board Meeting Outcome

The board of directors, in their meeting held on March 18, 2026, considered and approved the allotment of fully paid-up equity shares to promoter, promoter group, and non-promoter public category investors. The meeting commenced at 4:33 PM and concluded at 5:05 PM, with the outcome communicated to both BSE Limited and National Stock Exchange of India Limited under Regulation 30 of SEBI LODR Regulations.

Parameter:	Details
Meeting Date:	March 18, 2026
Total Shares Allotted:	20,79,409
Issue Price:	₹338 per share
Face Value:	₹5 per share
Premium:	₹333 per share

Investor-wise Allotment Details

The warrant conversion involved 8 investors across different categories, with Swastik Capital being the largest beneficiary. All warrant holders exercised their conversion option and paid the balance 75% consideration amount.

Investor:	Category	Shares Allotted	Consideration Amount (₹)
Swastik Capital:	Non-Promoter Public	7,82,574	19,83,82,509
Mr. Sajankumar Rameshwarlal Bajaj:	Promoter	4,55,074	11,53,61,259
Mr. Anil Champalal Jain:	Promoter Group	4,55,074	11,53,61,259
Dr. Ashish Garg:	Non-Promoter Public	1,77,515	4,50,00,052.50
Mr. Mohit Poddaar:	Non-Promoter Public	59,172	1,50,00,102
BH Lakhani:	Non-Promoter Public	50,000	1,26,75,000
U.K Vora:	Non-Promoter Public	50,000	1,26,75,000
Vimal Trading:	Non-Promoter Public	50,000	1,26,75,000

Capital Structure Impact

Following the allotment, the company's issued, subscribed and paid-up equity share capital has increased significantly. The newly allotted equity shares rank pari-passu with existing shares in all respects, including dividend rights.

Capital Structure:	Before Allotment	After Allotment
Paid-up Capital:	₹15,79,16,260	₹16,83,13,305
Number of Shares:	3,15,83,252	3,36,62,661
Face Value per Share:	₹5	₹5

Regulatory Compliance

The allotment was conducted in accordance with the special resolution passed by shareholders at the Extra-Ordinary General Meeting held on August 07, 2024, and complies with SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. The original warrants were allotted on September 19, 2024, with an 18-month conversion period. With this allotment, no warrants remain outstanding for conversion.